| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Rivaroxaban | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 2 | gemcitabine | FAERS: 3 | US FAERS | |
| 3 | Aspirin | FAERS: 2 | US FAERS | |
| 4 | Paclitaxel | FAERS: 2 | US FAERS | |
| 5 | Warfarin | FAERS: 2 | US FAERS | |
| 6 | Warfarin | FAERS: 2 | US FAERS | |
| 7 | Buprenorphine | FAERS: 1 | US FAERS | |
| 8 | Carmustine | FAERS: 1 | US FAERS | |
| 9 | Methamphetamine | FAERS: 1 | US FAERS | |
| 10 | Methotrexate | FAERS: 1 | US FAERS | |
| 11 | Octreotide | FAERS: 1 | US FAERS | |
| 12 | Sevelamer | FAERS: 1 | US FAERS | |
| 13 | lenvatinib | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120265
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.